Medexus secures public reimbursement for Cuvposa in Quebec

Medexus Pharmaceuticals

1 February 2023 - Medexus Pharmaceuticals wishes to inform investors that the company has reached an agreement with the provincial government of Quebec for government sponsored coverage of Cuvposa (glycopyrrolate 1 mg/5 mL oral solution). 

Cuvposa will be listed for public reimbursement on the Public Prescription Drug Insurance Plan of the Régime de l’Assurance Maladie du Québec, or RAMQ, starting 1 February 2023.

Read Medexus Pharmaceuticals press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Canada , Reimbursement , Quebec